ONEMEDNET CORPORATION Debt Instrument, Increase (Decrease), Net
ONEMEDNET CORPORATION (ONMD) reported Debt Instrument, Increase (Decrease), Net of $1.50 million for the 9-month period ending 2023-09-30, per its 10-Q/A filed 2023-12-18.
Discontinued › Notes
us-gaap:DebtInstrumentIncreaseDecreaseForPeriodNet · last filed 2023-12-18
- ONEMEDNET CORPORATION debt instrument, increase (decrease), net for the quarter ending 2023-09-30 was $0.00.
- ONEMEDNET CORPORATION debt instrument, increase (decrease), net for the quarter ending 2023-06-30 was $0.00.
- ONEMEDNET CORPORATION debt instrument, increase (decrease), net for the quarter ending 2023-03-31 was $1.50M, a 0.00% change year-over-year.
- ONEMEDNET CORPORATION debt instrument, increase (decrease), net for the quarter ending 2022-12-31 was $0.00.
- ONEMEDNET CORPORATION debt instrument, increase (decrease), net for fiscal 2022 was $1.50M.
| Period end | Debt Instrument, Increase (Decrease), Net 3 month | Debt Instrument, Increase (Decrease), Net 6 month | Debt Instrument, Increase (Decrease), Net 9 month | Debt Instrument, Increase (Decrease), Net 11 month | Debt Instrument, Increase (Decrease), Net 12 month |
|---|---|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2023-12-18 | $0.00 derived: sum of 2 quarters · filed 2023-12-18 | $1.50M 10-Q/A · filed 2023-12-18 | $1.50M derived: sum of 4 quarters · filed 2023-12-18 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.50M 10-Q · filed 2023-08-14 | $1.50M derived: sum of 3 quarters · filed 2023-08-14 | $1.50M derived: sum of 4 quarters · filed 2023-08-14 | |
| 2023-03-31 | $1.50M 10-Q · filed 2023-05-19 | $1.50M derived: sum of 2 quarters · filed 2023-05-19 | $1.50M derived: sum of 3 quarters · filed 2023-05-19 | $1.50M derived: sum of 4 quarters · filed 2023-05-19 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $0.00 derived: sum of 3 quarters · filed 2023-03-31 | $1.50M 10-K · filed 2023-03-31 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-18 | $0.00 derived: sum of 2 quarters · filed 2022-11-18 | $1.50M 10-Q · filed 2022-11-18 | ||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $1.50M 10-Q · filed 2022-08-15 | |||
| 2022-03-31 | $1.50M 10-Q · filed 2022-05-16 | ||||
| 2021-12-31 | $1.50M 10-K · filed 2022-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |